Literature DB >> 9183715

Opportunistic properties of Nosema algerae (Microspora), a mosquito parasite, in immunocompromised mice.

T Trammer1, F Dombrowski, M Doehring, W A Maier, H M Seitz.   

Abstract

In the last ten years microsporidia have been recognized as opportunistic pathogens in AIDS patients. The sources of infection and the mechanisms of transmission of these organisms in humans are mostly uncertain. Transmission of invertebrate microsporidia to mammals is normally considered impossible, temperature being a limiting factor for development. Mice treated with cortisone acetate and with cyclosporin A, respectively, as well as athymic nice were injected intravenously, intranasally, perorally and subcutaneously with spores of Nosema algerae, a microsporidian species of culicine mosquitoes. No infection could be detected in tissue samples of cortisone acetate and cyclosporin A treated mice. However, the experimental inoculation of spores into the tail and foot of athymic mice caused severe infection in skeletal muscles and the connective tissue. In some tails, nerve tissue and bone marrow were also infected. Vegetative stages and spores were seen in direct contact to host cell cytoplasma. For the first time the prolonged and progressive development of an invertebrate microsporidium in a mammalian host is shown. The possibility of invertebrate microsporidia as a source of human microsporidiosis should now be taken into consideration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9183715     DOI: 10.1111/j.1550-7408.1997.tb05709.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN: 1066-5234            Impact factor:   3.346


  9 in total

1.  Relevant criteria for detecting microsporidia in stool specimens.

Authors:  G Chioralia; T Trammer; H Kampen; H M Seitz
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

2.  An analysis of the microsporidian genus Brachiola, with comparisons of human and insect isolates of Brachiola algerae.

Authors:  Ann Cali; Louis M Weiss; Peter M Takvorian
Journal:  J Eukaryot Microbiol       Date:  2004 Nov-Dec       Impact factor: 3.346

Review 3.  Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia.

Authors:  C Franzen; A Müller
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

4.  In vitro growth of microsporidia Anncaliia algerae in cell lines from warm water fish.

Authors:  S Richelle Monaghan; Rebecca L Rumney; Nguyen T K Vo; Niels C Bols; Lucy E J Lee
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-11-18       Impact factor: 2.416

Review 5.  Zoonotic potential of the microsporidia.

Authors:  Alexander Mathis; Rainer Weber; Peter Deplazes
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

6.  Effects of host temperature and gastric and duodenal environments on microsporidia spore germination and infectivity of intestinal epithelial cells.

Authors:  Gordon J Leitch; Carolina Ceballos
Journal:  Parasitol Res       Date:  2008-08-27       Impact factor: 2.289

Review 7.  Microsporidia, a Highly Adaptive Organism and Its Host Expansion to Humans.

Authors:  Nirin Seatamanoch; Switt Kongdachalert; Sakone Sunantaraporn; Padet Siriyasatien; Narisa Brownell
Journal:  Front Cell Infect Microbiol       Date:  2022-06-16       Impact factor: 6.073

8.  Anncaliia algerae microsporidial myositis.

Authors:  Matthew R Watts; Renee C F Chan; Elaine Y L Cheong; Susan Brammah; Kate R Clezy; Chiwai Tong; Deborah Marriott; Cameron E Webb; Bobby Chacko; Vivienne Tobias; Alexander C Outhred; Andrew S Field; Michael V Prowse; James V Bertouch; Damien Stark; Stephen W Reddel
Journal:  Emerg Infect Dis       Date:  2014-02       Impact factor: 6.883

9.  Anncaliia algerae Microsporidial Myositis, New South Wales, Australia.

Authors:  Gaurav Sutrave; Adam Maundrell; Caitlin Keighley; Zoe Jennings; Susan Brammah; Min-Xia Wang; Roger Pamphlett; Cameron E Webb; Damien Stark; Helen Englert; David Gottlieb; Ian Bilmon; Matthew R Watts
Journal:  Emerg Infect Dis       Date:  2018-08       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.